Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice.

Mascarell L, Saint-Lu N, Moussu H, Zimmer A, Louise A, Lone Y, Ladant D, Leclerc C, Tourdot S, Van Overtvelt L, Moingeon P.

Mucosal Immunol. 2011 Nov;4(6):638-47. doi: 10.1038/mi.2011.28. Epub 2011 Jul 20.

PMID:
21775981
2.

Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.

Mascarell L, Lombardi V, Zimmer A, Louise A, Tourdot S, Van Overtvelt L, Moingeon P.

Clin Exp Allergy. 2009 Dec;39(12):1910-9. doi: 10.1111/j.1365-2222.2009.03337.x. Epub 2009 Aug 20.

PMID:
19694757
3.

Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.

Saint-Lu N, Tourdot S, Razafindratsita A, Mascarell L, Berjont N, Chabre H, Louise A, Van Overtvelt L, Moingeon P.

Allergy. 2009 Jul;64(7):1003-13. doi: 10.1111/j.1398-9995.2009.01945.x. Epub 2009 Feb 12.

4.

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.

Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H, Betbeder D, Balazuc AM, Van Overtvelt L, Moingeon P.

J Allergy Clin Immunol. 2008 Sep;122(3):603-9.e5. doi: 10.1016/j.jaci.2008.06.034.

PMID:
18774396
5.

Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.

Lombardi V, Van Overtvelt L, Horiot S, Moussu H, Chabre H, Louise A, Balazuc AM, Mascarell L, Moingeon P.

Clin Exp Allergy. 2008 Nov;38(11):1819-29. doi: 10.1111/j.1365-2222.2008.03056.x. Epub 2008 Jul 17.

PMID:
18644025
6.
7.

IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model.

Van Overtvelt L, Lombardi V, Razafindratsita A, Saint-Lu N, Horiot S, Moussu H, Mascarell L, Moingeon P.

Int Arch Allergy Immunol. 2008;145(2):152-62. Epub 2007 Sep 11.

PMID:
17848808
8.

CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma.

Boudousquié C, Pellaton C, Barbier N, Spertini F.

Clin Exp Allergy. 2009 Sep;39(9):1415-26. doi: 10.1111/j.1365-2222.2009.03314.x. Epub 2009 Jul 16.

PMID:
19624523
9.

Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.

Huang H, Dawicki W, Zhang X, Town J, Gordon JR.

J Immunol. 2010 Nov 1;185(9):5003-10. doi: 10.4049/jimmunol.0903446. Epub 2010 Sep 24.

10.

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.

Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P.

Gastroenterology. 2007 Aug;133(2):517-28. Epub 2007 May 3.

PMID:
17681173
12.

Oral tolerance induction by partially hydrolyzed whey protein in mice is associated with enhanced numbers of Foxp3+ regulatory T-cells in the mesenteric lymph nodes.

van Esch BC, Schouten B, de Kivit S, Hofman GA, Knippels LM, Willemsen LE, Garssen J.

Pediatr Allergy Immunol. 2011 Dec;22(8):820-6. doi: 10.1111/j.1399-3038.2011.01205.x. Epub 2011 Sep 21.

PMID:
21933283
13.

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P.

J Allergy Clin Immunol. 2007 Aug;120(2):278-85. Epub 2007 May 25.

PMID:
17531296
14.

Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance.

Fear VS, Burchell JT, Lai SP, Wikstrom ME, Blank F, von Garnier C, Turner DJ, Sly PD, Holt PG, Strickland DS, Stumbles PA.

J Immunol. 2011 Nov 1;187(9):4561-70. doi: 10.4049/jimmunol.1004189. Epub 2011 Sep 19.

15.
16.
17.

Cortex Mori Radicis extract exerts antiasthmatic effects via enhancement of CD4(+)CD25(+)Foxp3(+) regulatory T cells and inhibition of Th2 cytokines in a mouse asthma model.

Kim HJ, Lee HJ, Jeong SJ, Lee HJ, Kim SH, Park EJ.

J Ethnopharmacol. 2011 Oct 31;138(1):40-6. doi: 10.1016/j.jep.2011.08.021. Epub 2011 Aug 22.

PMID:
21875661
18.

Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy.

Maazi H, Shirinbak S, Willart M, Hammad HM, Cabanski M, Boon L, Ganesh V, Baru AM, Hansen G, Lambrecht BN, Sparwasser T, Nawijn MC, van Oosterhout AJ.

Clin Exp Allergy. 2012 Oct;42(10):1519-28. doi: 10.1111/j.1365-2222.2012.04064.x.

PMID:
22994349
19.

UV inhibits allergic airways disease in mice by reducing effector CD4 T cells.

McGlade JP, Strickland DH, Lambert MJ, Gorman S, Thomas JA, Judge MA, Burchell JT, Zosky GR, Hart PH.

Clin Exp Allergy. 2010 May;40(5):772-85. doi: 10.1111/j.1365-2222.2010.03469.x. Epub 2010 Mar 4.

PMID:
20214669
20.

Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.

Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C.

J Allergy Clin Immunol. 2007 Sep;120(3):707-13. Epub 2007 Aug 6.

PMID:
17681368

Supplemental Content

Support Center